Table 5.
CD44/FKBPL ratio (>155.10) at 20 weeks of gestation is an independent risk factor for developing preeclampsia
| CD44/FKBPL ratio at 20 weeks gestation | Controls | Cases | OR (95% CI) | P-value |
|---|---|---|---|---|
| CD44/FKBPL ratio < 155.10 | 33 (60) | 21 (39) | 1.0a | |
| CD44/FKBPL ratio > 155.10 | 22 (40) | 33 (61) | 2.33 (1.05–5.17) | 0.038 |
| Clinical characteristics | ||||
| BMI (kg/m2) | 25.78 ± 4.01 | 26.93 ± 5.03 | 0.97 (0.88–1.07) | 0.531 |
| Age (years) | 30.14 ± 3.58 | 30.18 ± 4.16 | 0.94 (0.85–1.05) | 0.279 |
| Weight change (kg) | 3.19 ± 1.92 | 2.87 ± 2.00 | 0.91 (0.75–1.11) | 0.354 |
| MAP (mmHg) | 80.13 ± 7.10 | 84.13 ± 8.01 | 0.99 (0.94–1.05) | 0.876 |
CD44/FKBPL ratios are given as n (%) for both cases and controls. All clinical characteristics are given as mean ± SD for both cases and controls. Bolded P-values indicate a significant difference between the two groups.
Abbreviations: BMI, body mass index; CI, confidence interval; MAP, mean arterial pressure; OR, odds ratio.
aReference category.